Commercialization of Novel Biomarkers

Novel biomarkers face both scientific as well as market challenges that all need to be overcome to achieve commercial success. Rx Dx Advisors can help you:

  • Evaluate the current evidence for the clinical utility of the proposed biomarker
  • Design and execute publishable biomarker validation studies
  • Select the optimal assay platform for biomarker commercilaization
  • Develop a go-to-market strategy to educate prescribing physicians and insurance providers on how to use the new biomarker assay to improve patient care

News & Updates

Get Updated at AMP in Salt Lake City

Coming to the Association for Molecular Pathology meeting... LEARN MORE >

San Diego – A Powerhouse Genomics Hub

The San Diego Economic Development Corp. just published &... LEARN MORE >

More News >

RxDx Advisors, Inc., San Diego, CA  //   Privacy Policy   //   San Diego Website Design